Open Access
Med Sci (Paris)
Volume 34, Number 6-7, Juin–Juillet 2018
Les Cahiers de Myologie
Page(s) 501 - 504
Section Le Magazine
Published online 31 July 2018
  1. Beaglehole R, Bonita R. Global public health: a scorecard. Lancet 2008 ; 372 : 1988–1996. [CrossRef] [PubMed] [Google Scholar]
  2. Hamze M, Desmetz C, Guglielmi P. Les lymplocytes B : une cible prometteuse pour traiter l’arthérosclérose ?. Med Sci (Paris) 2014 ; 30 : 874–881. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 ; 352 : 1685–1695. [Google Scholar]
  4. Avraham R, Yarden Y. Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 2011 ; 12 : 104–117. [CrossRef] [PubMed] [Google Scholar]
  5. Gschwind A, Fischer OM, Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 2004 ; 4 : 361–370. [Google Scholar]
  6. Lamb DJ, Modjtahedi H, Plant NJ, Ferns GA. EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis 2004 ; 176 : 21–26. [CrossRef] [PubMed] [Google Scholar]
  7. Stanic B, Pandey D, Fulton DJ, Miller FJ, Jr. Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis. Arterioscler Thromb Vasc Biol 2012 ; 32 : 2452–2460. [CrossRef] [PubMed] [Google Scholar]
  8. Nakata A, Miyagawa J, Yamashita S, et al. Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HB-EGF in the formation of coronary atherosclerosis. Circulation 1996 ; 94 : 2778–2786. [CrossRef] [PubMed] [Google Scholar]
  9. Matsumoto S, Kishida K, Shimomura I, et al. Increased plasma HB-EGF associated with obesity and coronary artery disease. Biochem Biophys Res Commun 2002 ; 292 : 781–786. [Google Scholar]
  10. Zeboudj L, Maitre M, Guyonnet L, et al. Selective EGF-receptor inhibition in CD4+ T cells induces anergy and limits atherosclerosis. J Am Coll Cardiol 2018 ; 71 : 160–172. [CrossRef] [PubMed] [Google Scholar]
  11. Zeboudj L, Giraud A, Guyonnet L, et al. Selective EGFR (epidermal growth factor receptor) deletion in myeloid cells limits atherosclerosis-Brief report. Arterioscler Thromb Vasc Biol 2018 ; 38 : 114–119. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.